Early Peripheral Blood Blast Clearance: A New Chemosensitivity Indicator for Acute Myeloid Leukemia
Journal: Scholarena Journal of Cancer Science (Vol.1, No. 1)Publication Date: 2014-09-04
Authors : Su Long;
Page : 1-2
Keywords : Acute Myeloid Leukemia; Peripheral Blood Blast;
Abstract
Acute myeloid leukemia (AML) is a highly heterogeneous disease, and cytogenetics and molecular markers play important roles in the diagnosis, treatment, and prognosis of AML. Although cytogenetic karyotypes and molecular mutations are powerful prognostic predictors for outcome of AML patients, indicators of response to initiation chemotherapy have not been identified. In childhood acute lymphoblastic leukemia, a rapid decline of circulating leukemic blasts in response to induction chemotherapy or prednisone is one of the most important prognostic factors, not only for achieving remission but also for long-term survival
Other Latest Articles
- Способи та порядок вручення письмового повідомлення про підозру
- Поліфункціональність кримінальної процесуальної діяльності слідчого
- A STUDY OF THE IMPACT OF COMMUNICATIVE ACTIVITIES ON THE DEVELOPMENT OF COMMUNICATIVE COMPETENCE IN WRITTEN ENGLISH OF SECONDARY SCHOOL LEARNERS
- Cancer Informatics: A Powerful Approach to Cancer Research in the Post-Genomic Age
- BIG DATA ANALYTICS: – CHALLENGES, OPEN RESEARCH ISSUES FOR COMPUTER SCIENCE EDUCATION
Last modified: 2018-11-28 20:14:08